Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | E-7-027 |
Topic: | Pneumatic Compression Devices |
Section: | Durable Medical Equipment |
Effective Date: | July 2, 2018 |
Issue Date: | July 2, 2018 |
Last Reviewed: | February 2018 |
A pneumatic compression therapy device functions as a pump to improve circulation. The device consists of an inflatable garment, usually for the arm, leg, and/or ankle, and an electric pump. The inflatable garment is intermittently inflated and deflated in a cycle of time and pressure. Pneumatic compression therapy devices are classified as non-segmented or segmented, with or without calibrated gradient pressure. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
Pneumatic compression devices/lymphedema pumps and appliances for in-home use may be covered as durable medical equipment (DME) when ALL of the following are met:
Segmented or non-segmented pneumatic compression devices without calibrated gradient pressure for in-home use may be considered medically necessary for the treatment of ANY ONE of the following:
OR
OR
In-home use of limb compression devices for the following indications may be considered medically necessary for ANY ONE of the following:
The in-home use of limb compression devices for VTE prophylaxis for the following conditions, are considered experimental/investigational and, therefore, non-covered:
The efficacy of these devices for the above conditions is unproven.
A portable, intermittent, limb compression device (i.e. Vena Pro) is considered experimental/ investigational and, therefore, non-covered. There is a lack of evidence based literature to confirm the efficacy and safety of these devices.
In-home use of limb compression devices for VTE prophylaxis for periods longer than 30 days post-surgery is not medically necessary.
Segmented pneumatic compression therapy devices with calibrated gradient pressure may be considered medically necessary for in-home use when the following medical necessity criteria are met:
The use of pneumatic compression devices for the treatment of lymphedema of the head, neck, chest or trunk, and/or the treatment of arterial insufficiency, is considered experimental/investigational and, therefore, non-covered. The evidence is insufficient to determine the effects of the technology on health outcomes.
Professional Statements and Societal Positions |
Guidance on Determining High Risk for Bleeding American College of Chest Physicians (ACCP) 2012 guidelines on prevention of VTE in orthopedic surgery patients list the following general risk factors for bleeding:
The guidelines note, however, that “specific thresholds for using mechanical compression devices or no prophylaxis instead of anticoagulant thromboprophylaxis have not been established.” Guidance on Risk Level for Patients Undergoing Non-orthopedic Surgery The 2012 ACCP guidelines on prevention of VTE in non-orthopedic surgery patients included the following discussion of risk levels: “In patients undergoing general and abdominal-pelvic surgery, the risk of VTE varies depending on both patient-specific and procedure-specific factors. Examples of relatively low-risk procedures include laparoscopic cholecystectomy, appendectomy, transurethral prostatectomy, inguinal herniorrhaphy, and unilateral or bilateral mastectomy. Open-abdominal and open-pelvic procedures are associated with a higher risk of VTE. VTE risk appears to be highest for patients undergoing abdominal or pelvic surgery for cancer…” “Independent risk factors include age at least 60 years, prior VTE, and cancer; age greater than or equal to 60 years, prior VTE, anesthesia greater than or equal to 2 hours, and bed rest greater than or equal to 4 days; older age, male sex, longer length of hospital stay, and higher Charlson comorbidity score; and sepsis, pregnancy or postpartum state, central venous access, malignancy, prior VTE, and inpatient hospital stay more than 2 days. In another study, most of the moderate to strong independent risk factors for VTE were surgical complications, including urinary tract infection, acute renal insufficiency, postoperative transfusion, perioperative myocardial infarction, and pneumonia”. The American College of Obstetricians and Gynecologists (ACOG, 2007, reaffirmed 2012) proposed the following risk classification for VTE in patients undergoing major gynecological surgery:
|
Place of Service: Outpatient |
Experimental/Investigational (E/I) services are not covered regardless of place of service.
Pneumatic Compression Devices are typically an outpatient service which is only eligible for coverage as an inpatient service in special circumstances including, but not limited to the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.
The policy position applies to all commercial lines of business |
Denial Statements |
Services that do not meet the criteria of this policy will not be considered medically necessary. A network provider cannot bill the member for the denied service unless: (a) the provider has given advance written notice, informing the member that the service may be deemed not medically necessary; (b) the member is provided with an estimate of the cost; and (c) the member agrees in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Links |
02/2016 Criteria Revised for Outpatient Pneumatic Compression Devices
04/2018 Criteria Revised for Pneumatic Compression Devices